Leprosy susceptibility: Genetic variations regulate innate and adaptive immunity, and disease outcome

Future Microbiology

Volumn 6, Issue 5, 2011, Pages 533-549

  Cardoso, Cynthia Chester ^a   Pereira, Ana Carla ^b   De Sales Marques, Carolinne ^a   Moraes, Milton Ozório ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

Author keywords

autophagy; cytokines; genetics; granuloma; infectious; leprosy; lipid bodies; population; SNPs; TNF; vitamin D

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; LEUKOTRIENE A4 HYDROLASE; LIPOXIN A; MANNOSE RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; VITAMIN D; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOPHAGOSOME; CELL METABOLISM; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DISEASE SEVERITY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME; GRANULOMA; HELPER CELL; HLA SYSTEM; HOST PATHOGEN INTERACTION; HUMAN; IFNG GENE; IMMUNE RESPONSE; INNATE IMMUNITY; LEPROSY; LRRK2 GENE; LTA GENE; MYCOBACTERIUM LEPRAE; NONHUMAN; OUTCOME ASSESSMENT; PACRG GENE; PARK2 GENE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LEPROSY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM LEPRAE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

MYCOBACTERIUM LEPRAE;

EID: 79956078781     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.39     Document Type: Review

References (154)

1. Moraes MO, Cardoso CC, Vanderborght PR, Pacheco AG: Genetics of host response in leprosy. Lepr. Rev, 77(3), 189-202 (2006). (Pubitemid 44901762)
2. Monot M, Honore N, Garnier T et al.: On the origin of leprosy. Science 308(5724), 1040-1042 (2005). (Pubitemid 40664418)
3. Monot M, Honoré N, Garnier T et al.: Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat. Genet. 41(12), 1282-1289 (2009).
4. Singh P, Cole ST: Mycobacterium leprae: Genes, pseudogenes and genetic diversity. Future Microbiol. 6(1), 57-71 (2011).
5. Pinheiro RO SJ, Sarno EM, Sampaio EP: Mycobacterium leprae - host-cell interactions and genetic determinants in leprosy: An overview Future Microbiol. 6(2), 217-230 (2011).
6. Ridley DS, Jopling WH: Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis. 34, 255-273 (1966).
7. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL: The continuing challenges of leprosy. Clin. Microbiol. Rev. 19(2), 338-381 (2006).
8. Alter A, Grant A, Abel L, Alcais A, Schurr E: Leprosy as a genetic disease. Mamm. Genome 22(1-2), 19-31 (2011).
9. Chakravartti M, Vogel F: A twin study on leprosy. In: Topics in Human Genetics. Georg Thieme, Stuttgart, Germany 1-123 (1973).
10. Shields ED, Russell DA, Pericak-Vance MA: Genetic epidemiology of the susceptibility to leprosy. J. Clin. Invest. 79(4), 1139-1143 (1987). (Pubitemid 17065495)
11. Abel L, Demenais F: Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade island. Am. J. Hum. Genet. 42(2), 256-266 (1988). n Seminal paper that describes the results of complex segregation analysis developed in families of a Caribbean island. Results suggested that different genes could control susceptibility to leprosy per se.
12. Beiguelman B: The genetics of resistance to leprosy. Int. J. Lepr. 33(4), 808-812 (1965).
13. Beiguelman B: Leprosy and genetics. A review of past research with remarks concerning future investigations. Bull. World Health Organ. 37(3), 461-476 (1967).
14. Beiguelman B: Some remarks on the genetics of leprosy resistance. Acta Genet. Med. Gemellol. (Roma) 17(4), 584-594 (1968).
15. Feitosa MF, Borecki I, Krieger H, Beiguelman B, Rao DC: The genetic epidemiology of leprosy in a Brazilian population. Am. J. Hum. Genet. 56(5), 1179-1185 (1995).
16. Lazaro FP, Werneck RI, Mackert CC et al.: A major gene controls leprosy susceptibility in a hyperendemic isolated population from north of Brazil. J. Infect. Dis. 201(10), 1598-1605 (2010).
17. Bellamy R: The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. Microbes Infect. 1(1), 23-27 (1999). (Pubitemid 29364908)
18. Malo D, Vidal SM, Hu J, Skamene E, Gros PL: High-resolution linkage map in the vicinity of the host resistance locus BCG. Genomics 16(3), 655-663 (1993). (Pubitemid 23183485)
19. Vidal SM, Malo D, Vogan K, Skamene E, Gros P: Natural resistance to infection with intracellular parasites: Isolation of a candidate for BCG. Cell 73(3), 469-485 (1993). (Pubitemid 23143347)
20. Ji B, Perani EG, Petinom C, Grosset JH: Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrob. Agents Chemother. 40(2), 393-399 (1996). (Pubitemid 26049353)
21. Truman RW, Andrews PK, Robbins NY, Adams LB, Krahenbuhl JL, Gillis TP: Enumeration of Mycobacterium leprae using real-time PCR. PLoS Negl. Trop. Dis. 2(11), E328 (2008).
22. Longley R, Smith C, Fortin A et al.: Host resistance to malaria: Using mouse models to explore the host response. Mamm. Genome 22(1-2), 32-42 (2011).
23. Roy S, McGuire W, Mascie-Taylor CG et al.: Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J. Infect. Dis. 176(2), 530-532 (1997). (Pubitemid 27328782)
24. Santos AR, Suffys PN, Vanderborght PR et al.: Role of tumor necrosis factor-a and interleukin-10 promoter gene polymorphisms in leprosy. J. Infect. Dis. 186(11), 1687-1691 (2002). (Pubitemid 35379650)
25. Lee SB, Kim BC, Jin SH et al.: Missense mutations of the interleukin-12 receptor b 1 (IL12RB1) and interferon-g receptor 1 (IFNGR1) genes are not associated with susceptibility to lepromatous leprosy in Korea. Immunogenetics 55(3), 177-181 (2003). (Pubitemid 36819365)
26. Mira MT, Alcais A, Nguyen VT et al.: Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427(6975), 636-640 (2004). nn Describes PARK2 as a major gene in leprosy after the positional cloning of the 6q25 peak. (Pubitemid 38248483)
27. Alcais A, Alter A, Antoni G et al.: Stepwise replication identifies a low-producing lymphotoxin-a allele as a major risk factor for early-onset leprosy. Nat. Genet. 39(4), 517-522 (2007). nn Explains the positional cloning of the LTA gene after further characterization of a linkage peak at 6p21 and describes the single nucleotide polymorphisms at +80 site as a risk factor for early-onset leprosy. (Pubitemid 46514779)
28. Pacheco AG, Cardoso CC, Moraes MO: IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: A meta-analysis study. Hum. Genet. 123(5), 477-484 (2008).
29. Pereira AC, Brito-de-Souza VN, Cardoso CC et al.: Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun. 10(2), 174-180 (2009).
30. Cardoso CC, Pereira AC, Brito-de-Souza VN et al.: IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians. Hum. Genet. 128(5), 481-490 (2010).
31. Misch EA, Macdonald M, Ranjit C et al.: Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl. Trop. Dis. 2(5), E231 (2008).
32. Berrington WR, Macdonald M, Khadge S et al.: Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states. J. Infect. Dis. 201(9), 1422-1435 (2010).
33. Sapkota BR, Macdonald M, Berrington WR et al.: Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes. Hum. Immunol. 71(10), 992-998 (2010).
34. de Messias-Reason IJ, Boldt AB, Moraes Braga AC et al.: The association between mannan-binding lectin gene polymorphism and clinical leprosy: New insight into an old paradigm. J. Infect. Dis. 196(9), 1379-1385 (2007). (Pubitemid 351412011)
35. Bochud PY, Hawn TR, Siddiqui MR et al.: Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J. Infect. Dis. 197(2), 253-261 (2008). (Pubitemid 351263444)
36. Jamieson SE, Miller EN, Black GF et al.: Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun. 5(1), 46-57 (2004). (Pubitemid 38967629)
37. Silva SR, Tempone AJ, Silva TP et al.: Mycobacterium leprae downregulates the expression of PHEX in Schwann cells and osteoblasts. Mem. Inst. Oswaldo Cruz. 105(5), 627-632 (2010).
38. Hawn TR, Misch EA, Dunstan SJ et al.: A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur. J. Immunol. 37(8), 2280-2289 (2007). (Pubitemid 47250219)
39. Johnson CM, Lyle EA, Omueti KO et al.: Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 178(12), 7520-7524 (2007). (Pubitemid 46898019)
40. Wong SH, Gochhait S, Malhotra D et al.: Leprosy and the adaptation of human Toll-like receptor 1. PLoS Pathog. 6, E1000979 (2010).
41. Liu PT, Stenger S, Li H et al.: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768), 1770-1773 (2006).
42. Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V: Toll-like receptors control autophagy. EMBO J. 27(7), 1110-1121 (2008). (Pubitemid 351508141)
43. Shin DM, Yuk JM, Lee HM et al.: Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol. 12(11), 1648-1665 (2010).
44. Zhang FR, Huang W, Chen SM et al.: Genomewide association study of leprosy. N. Engl. J. Med. 361(27), 2609-2618 (2009). nn Describes the first genome-wide association study in leprosy, which confirmed previous associations and described the effect of new genes such as NOD2 and LRRK2 in leprosy susceptibility.
45. Berrington WR, Macdonald M, Khadge S et al.: Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states. J. Infect. Dis. 201(9), 1422-1435 (2010).
46. Alter A, Alcais A, Abel L, Schurr E: Leprosy as a genetic model for susceptibility to common infectious diseases. Hum. Genet. 123(3), 227-235 (2008).
47. Cooney R, Baker J, Brain O et al.: NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16(1), 90-97 (2010).
48. Intemann CD, Thye T, Niemann S et al.: Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog. 5(9), E1000577 (2009).
49. Schurr E, Gros P: A common genetic fingerprint in leprosy and Crohn's disease? N. Engl. J. Med. 361(27), 2666-2668 (2009).
50. Ferwerda G, Girardin SE, Kullberg BJ et al.: NOD2 and Toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog. 1(3), 279-285 (2005).
51. Le Bourhis L, Benko S, Girardin SE: Nod1 and Nod2 in innate immunity and human inflammatory disorders. Biochem. Soc. Trans. 35(Pt 6), 1479-1484 (2007).
52. Siddiqui MR, Meisner S, Tosh K et al.: A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat. Genet. 27(4), 439-441 (2001). (Pubitemid 32268428)
53. Mira MT, Alcais A, Van Thuc N et al.: Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat. Genet. 33(3), 412-415 (2003). (Pubitemid 36278860)
54. Kerrigan AM, Brown GD: C-type lectins and phagocytosis. Immunobiology 214(7), 562-575 (2009).
55. Alter A, de Léséleuc L, Van Thuc N et al.: Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility. Hum. Genet. 127(3), 337-348 (2010).
56. Wang L, Chen RF, Liu JW et al.: DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl. Trop. Dis. 5(1), E934 (2011).
57. Sakuntabhai A, Turbpaiboon C, Casademont I et al.: A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37(5), 507-513 (2005). (Pubitemid 40617279)
58. Tabouret G, Astarie-Dequeker C, Demangel C et al.: Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes. PLoS Pathog. 6(10), E1001159 (2010).
59. Li X, Yang Y, Zhou F et al.: SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: Updated systematic review and meta-analysis. PLoS One, 6(1), E15831 (2011).
60. Krutzik SR, Tan B, Li H et al.: TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11(6), 653-660 (2005). (Pubitemid 40868306)
61. Matzner M, Al Samie AR, Winkler HM et al.: Low serum levels of cathelicidin LL-37 in leprosy. Acta Trop. 117(1), 56-59 (2011).
62. Krutzik SR, Hewison M, Liu PT et al.: IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181(10), 7115-7120 (2008).
63. Montoya D, Cruz D, Teles RM et al.: Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6(4), 343-353 (2009).
64. Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H, Pols HA: Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J. Steroid Biochem. Mol. Biol. 89-90(1-5), 187-193 (2004). (Pubitemid 38844281)
65. Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV: Association of vitamin D receptor genotype with leprosy type. J. Infect. Dis. 179(1), 187-191 (1999). (Pubitemid 29028354)
66. Fitness J, Floyd S, Warndorff DK et al.: Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. Am. J. Trop. Med. Hyg. 71(3), 330-340 (2004). (Pubitemid 39223511)
67. Velarde Félix JS, Cazarez Salazar SG, Castro Velázquez R, Rendan Maldonado JG, Rangel Villalobos H: Relación del polimorfismo TaqI del gen del receptor de la vitamina D con la lepra lepromatosa en población mexicana. Salud Pública de México, 51, 59-61 (2009).
68. Goulart LR, Ferreira FR, Goulart IM: Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy. FEMS Immunol. Med. Microbiol. 48(1), 91-98 (2006). (Pubitemid 44379224)
69. Sapkota BR, Macdonald M, Berrington WR et al.: Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes. Hum. Immunol. 71(10), 992-998 (2010).
70. Prado-Montes de Oca E, Velarde-Felix JS, Rios-Tostado JJ, Picos-Cardenas VJ, Figuera LE: SNP 668C (-44) alters a NF-kB1 putative binding site in non-coding strand of human b-defensin 1 (DEFB1) and is associated with lepromatous leprosy. Infect. Genet. Evol. 9(4), 617-625 (2009).
71. Malhotra D, Darvishi K, Lohra M et al.: Association study of major risk single nucleotide polymorphisms in the common regulatory region of PARK2 and PACRG genes with leprosy in an Indian population. Eur. J. Hum. Genet. 14(4), 438-442 (2005).
72. Berger AK, Cortese GP, Amodeo KD, Weihofen A, Letai A, LaVoie MJ: Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Hum. Mol. Genet. 18(22), 4317-4328 (2009). n Links parkin to one of the apoptosis pathways since it shows that parkin associates with mitochondria and inhibits cytochrome c release.
73. Chen D, Gao F, Li B et al.: Parkin mono-ubiquitinates Bcl-2 and regulates autophagy. J. Biol. Chem. 285(49), 38214-38223 (2010).
74. Smith WW, Pei Z, Jiang H et al.: Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl Acad. Sci. USA 102(51), 18676-18681 (2005). (Pubitemid 43011285)
75. Vives-Bauza C, Zhou C, Huang Y et al.: PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl Acad. Sci. USA 107(1), 378-383 (2010).
76. Deretic V: Autophagy in infection. Curr. Opin. Cell Biol. 22(2), 252-262 (2010).
77. Spandl J, Lohmann D, Kuerschner L, Moessinger C, Thiele C: Ancient ubiquitous protein 1 (AUP1) localizes to lipid droplets and binds the E2 ubiquitin conjugase G2 (UBE2G2) via its G2 binding region. J. Biol. Chem. 286(7), 5599-5606 (2011).
78. Tobin DM, Vary JC, Ray JP et al.: The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140(5), 717-730 (2010). nn The authors used a zebrafish model and found a clear role for the lta4h gene in severe susceptibility to Mycobacterium marinum infection. Further investigations showed an association between the human LTA4H gene and susceptibility to TB and multibacillary leprosy.
79. Chen M, Divangahi M, Gan H et al.: Lipid mediators in innate immunity against tuberculosis: Opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205(12), 2791-2801 (2008).
80. Cruz D, Watson AD, Miller CS et al.: Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J. Clin. Invest. 118(8), 2917-2928 (2008).
81. Kim MJ, Wainwright HC, Locketz M et al.: Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2(7), 258-274 (2010).
82. Mattos KA, D'Avila H, Rodrigues LS et al.: Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J. Leuk. Biol. 87(3), 371-384 (2010). nn Describes the induction of lipid droplets in cells infected with Mycobacterium leprae and describes the lipid droplets as intracellular sites for the synthesis of eicosanoids such as PGE2.
83. Mattos KA, Lara FA, Oliveira VGC et al.: Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: A putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell. Microbiol. 13(2), 259-273 (2011).
84. Misra N, Selvakumar M, Singh S et al.: Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy. Immunol. Lett. 48(2), 123-128 (1995). (Pubitemid 26014798)
85. Tanigawa K, Suzuki K, Nakamura K et al.: Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae. FEMS Microbiol. Lett. 289(1), 72-79 (2008).
86. Singh R, Kaushik S, Wang Y et al.: Autophagy regulates lipid metabolism. Nature 458(7242), 1131-1135 (2009).
87. Tobin DM, Ramakrishnan L: Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell. Microbiol. 10(5), 1027-1039 (2008). (Pubitemid 351540503)
88. Scollard DM, Joyce MP, Gillis TP: Development of leprosy and type 1 leprosy reactions after treatment with infliximab: A report of 2 cases. Clin. Infect. Dis. 43(2), E19-E22 (2006).
89. Hagge DA, Saunders BM, Ebenezer GJ et al.: Lymphotoxin-a and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy. Am. J. Pathol. 174(4), 1379-1389 (2009).
90. Roy S, McGuire W, Mascie-Taylor CG et al.: Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J. Infect. Dis. 176(2), 530-532 (1997). (Pubitemid 27328782)
91. Shaw MA, Donaldson IJ, Collins A et al.: Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun. 2(4), 196-204 (2001). (Pubitemid 33676983)
92. Vejbaesya S, Mahaisavariya P, Luangtrakool P, Sermduangprateep C: TNF a and NRAMP1 polymorphisms in leprosy. J. Med. Assoc. Thai. 90(6), 1188-1192 (2007).
93. Franceschi DSA, Mazini PS, Rudnick CCC et al.: Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int. J. Infect. Dis. 13(4), 493-498 (2009).
94. Santos AR, Almeida AS, Suffys PN et al.: Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients. Int. J. Lepr. Other Mycobact. Dis. 68(3), 325-327
95. Cardoso CC, Pereira AC, Brito-de-Souza VN et al.: TNF -308G>A single nucleotide polymorphism is associated with leprosy among Brazilians: A genetic epidemiology assessment, meta-analysis and functional study. J. Infect. Dis. (2011) (In press).
96. Moraes MO, Duppre NC, Suffys PN et al.: Tumor necrosis factor-alpha promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensitivity reaction in the skin of borderline tuberculoid leprosy patients. Immunogenetics 53(1), 45-47 (2001). (Pubitemid 32209412)
97. Knight JC, Keating BJ, Kwiatkowski DP: Allele-specific repression of lymphotoxin-a by activated B cell factor-1. Nat. Genet. 36(4), 394-399 (2004). (Pubitemid 38437263)
98. van de Vosse E, van Dissel JT, Ottenhoff TH: Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect. Dis. 9(11), 688-698 (2009).
99. Al-Muhsen S, Casanova J-L: The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J. Allergy Clin. Immunol. 122(6), 1043-1051 (2008).
100. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV: In vitro production of IFN-g correlates with CA repeat polymorphism in the human IFN-g gene. Eur. J. Immunogen. 26(1), 1-3 (1999). (Pubitemid 29060633)
101. Pravica V, Perrey C, Stevens A, Lee J-H, Hutchinson IV: A single nucleotide polymorphism in the first intron of the human IFN-g gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN g production. Hum. Immunol. 61(9), 863-866 (2000).
102. Lopez-Maderuelo D, Arnalich F, Serantes R et al.: Interferon-g and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 167(7), 970-975 (2003). (Pubitemid 36408162)
103. Sallakci N, Coskuna M, Berberb Z et al.: Interferon-g gene+874T-A polymorphism is associated with tuberculosis and g interferon response. Tuberculosis (Edinb.) 87(3), 225-230 (2007). (Pubitemid 46551843)
104. Pacheco A, Cardoso C, Moraes M: IFNG+874T/A, IL10-1082G/A and TNF-308G/A polymorphisms in association with tuberculosis susceptibility: A meta-analysis study. Hum. Genet. 123(5), 477-484 (2008).
105. Cardoso C, Pereira A, Brito-de-Souza V et al.: IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians. Hum. Genet. 128(5), 481-490 (2010).
106. Alvarado-Navarro A, Montoya-Buelna M, Muñoz-Valle JF, López-Roa RI, Guillén-Vargas C, Fafutis-Morris M: The 3'UTR 1188 A/C polymorphism in the interleukin-12p40 gene (IL-12B) is associated with lepromatous leprosy in the west of Mexico. Immunol. Lett. 118(2), 148-151 (2008).
107. Morahan G, Kaur G, Singh M et al.: Association of variants in the IL12B gene with leprosy and tuberculosis. Tissue Antigens 69(Suppl. 1), 234-236 (2007). (Pubitemid 46625891)
108. Ohyama H, Ogata K, Takeuchi K et al.: Polymorphism of the 5' flanking region of the IL-12 receptor b2 gene partially determines the clinical types of leprosy through impaired transcriptional activity. J. Clin. Pathol. 58(7), 740-743 (2005). (Pubitemid 40956830)
109. Horton R, Gibson R, Coggill P et al.: Variation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project. Immunogenetics 60(1), 1-18 (2008).
110. Zinkernagel R: Major transplantation antigens in host responses to infection. Hosp. Pract. 13(7), 83-92 (1978). (Pubitemid 8386725)
111. Mira MT, Alcais A, di Pietrantonio T et al.: Segregation of HLA/TNF region is linked to leprosy clinical spectrum in families displaying mixed leprosy subtypes. Genes Immun. 4(1), 67-73 (2003). (Pubitemid 38967576)
112. Wong SH, Gochhait S, Malhotra D et al.: Leprosy and the adaptation of human Toll-like receptor 1. PLoS Pathog. 6, E1000979 (2010).
113. Blackwell JM, Jamieson SE, Burgner D: HLA and infectious diseases. Clin. Microbiol. Rev. 22(2), 370-385 (2009).
114. Kim SJ CI, Dahlberg S, Nisperos B, Kim JD, Hansen JA: HLA and leprosy in Koreans. Tissue Antigens 29(3), 146-153 (1987). (Pubitemid 17078581)
115. Shankarkumar U: HLA associations in leprosy patients from Mumbai, India. Lepr. Rev. 75(1), 79-85 (2004). (Pubitemid 38374525)
116. Franceschi DS, Mazini PS, Rudnick CC et al.: Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. Tissue Antigens 72(5), 478-482 (2008).
117. Ohyama H, Matsushita S, Nishimura F et al.: T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy. Vaccine 20(3-4), 475-482 (2001). (Pubitemid 32973791)
118. Visentainer JEL, Tsuneto LT, Serra MF, Peixoto PR, Petzl-Erler ML: Association of leprosy with HLA-DR2 in a Southern Brazilian population. Braz. J. Med. Biol. Res. 30(1), 51-59 (1997). (Pubitemid 127517364)
119. van Eden W, Gonzalez NM, de Vries RR, Convit J, van Rood JJ: HLA-linked control of predisposition to lepromatous leprosy. J. Infect. Dis. 151(1), 9-14 (1985). (Pubitemid 15192875)
120. de Vries RR, Mehra NK, Vaidya MC, Gupte MD, Meera Khan P, Van Rood JJ: HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types. Tissue Antigens 16(4), 294-304 (1980). (Pubitemid 10024294)
121. Cem Mat M, Yazici H, Ozbakir F, Tüzün Y: The HLA association of lepromatous leprosy and borderline lepromatous leprosy in Turkey. A preliminary study. Int. J. Dermatol. 27(4), 246-247 (1988).
122. Schauf V, Ryan S, Scollard D et al.: Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand. Tissue Antigens 26(4), 243-247 (1985). (Pubitemid 16232252)
123. Wang LM, Kimura A, Satoh M, Mineshita S: HLA linked with leprosy in southern China: HLA-linked resistance alleles to leprosy. Int. J. Lepr. Other Mycobact. Dis. 67(4), 403-408 (1999). (Pubitemid 30090421)
124. Vanderborght PR, Pacheco AG, Moraes ME et al.: HLA-DRB1*04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients. Genes Immun. 8(4), 320-324 (2007). (Pubitemid 46888039)
125. Rani R, Fernandez-Vina MA, Zaheer SA, Beena KR, Stastny P: Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens 42(3), 133-137 (1993). (Pubitemid 23295481)
126. Singh M, Balamurugan A, Katoch K, Sharma SK, Mehra NK: Immunogenetics of mycobacterial infections in the North Indian population. Tissue Antigens 69, 228-230 (2007). (Pubitemid 46625887)
127. Gorodezky C, Alaez C, Munguia A et al.: Molecular mechanisms of MHC linked susceptibility in leprosy: Towards the development of synthetic vaccines. Tuberculosis (Edinb.) 84(1-2), 82-92 (2004). (Pubitemid 38082936)
128. Joko S NJ, Kawashima H, Namisato M, Maeda H: Human leukocyte antigens in forms of leprosy among Japanese patients. Int. J. Lepr. Other Mycobact. Dis. 68(1), 49-56 (2000). (Pubitemid 30314148)
129. Zerva L, Cizman B, Mehra NK et al.: Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J. Exp. Med. 183(3), 829-836 (1996).
130. Koçak M, Balci M, Pençe B, Kundakçi N: Associations between human leukocyte antigens and leprosy in the Turkish population. Clin. Exp. Dermatol. 27(3), 235-239 (2002). (Pubitemid 34639290)
131. Ramagopalan SV, Maugeri NJ, Handunnetthi L et al.: Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 5(2), E1000369 (2009).
132. Yamamura M, Uyemura K, Deans RJ et al.: Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 254(5029), 277-279 (1991). (Pubitemid 21917340)
133. Sieling PA, Modlin RL: Cytokine patterns at the site of mycobacterial infection. Immunobiology 191(4-5), 378-387 (1994). (Pubitemid 24331463)
134. Lima MCBS, Pereira GMB, Rumjanek FD et al.: Immunological cytokine correlates of protective immunity and pathogenesis in leprosy. Scand. J. Immunol. 51(4), 419-428 (2000). (Pubitemid 30212286)
135. Santos AR, Suffys PN, Vanderborght PR et al.: Role of tumor necrosis factor-a and interleukin-10 promoter gene polymorphisms in leprosy. J. Infect. Dis. 186(11), 1687-1691 (2002). (Pubitemid 35379650)
136. Moraes MO, Pacheco AG, Schonkeren JJ et al.: Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy. Genes Immun. 5(7), 592-595 (2004). (Pubitemid 39529977)
137. Malhotra D, Darvishi K, Sood S et al.: IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. Hum. Genet. 118(2), 295-300 (2005). (Pubitemid 41672092)
138. Cole ST, Eiglmeier K, Parkhill J et al.: Massive gene decay in the leprosy bacillus. Nature 409(6823), 1007-1011 (2001). (Pubitemid 32204045)
139. Williams DL, Slayden RA, Amin A et al.: Implications of high level pseudogene transcription in Mycobacterium leprae. BMC Genomics 10, 397 (2009).
140. Akama T, Suzuki K, Tanigawa K et al.: Whole-genome expression analysis of Mycobacterium leprae and its clinical application. Jpn J. Infect. Dis. 63(6), 387-392 (2010).
141. Williams DL, Torrero M, Wheeler PR et al.: Biological implications of Mycobacterium leprae gene expression during infection. J. Mol. Microbiol. Biotechnol. 8(1), 58-72 (2004). (Pubitemid 40468749)
142. Stokes RW, Waddell SJ: Adjusting to a new home: Mycobacterium tuberculosis gene expression in response to an intracellular lifestyle. Future Microbiol. 4(10), 1317-1335 (2009).
143. Tapinos N, Rambukkana A: Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. Proc. Natl Acad. Sci. USA 102(26), 9188-9193 (2005). (Pubitemid 40923539)
144. Rambukkana A, Salzer JL, Yurchenco PD, Tuomanen EI: Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-a2 chain. Cell 88(6), 811-821 (1997). (Pubitemid 27164269)
145. Behr M, Schurr E, Gros P: TB: Screening for responses to a vile visitor. Cell 140(5) 615-618 (2010).
146. Frota CC, Freitas MV, Foss NT et al.: Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil. Trans. R Soc. Trop. Med. Hyg. 104(7), 490-495 (2010).
147. Paige C, Bishai WR: Penitentiary or penthouse condo: The tuberculous granuloma from the microbe's point of view. Cell. Microbiol. 12(3), 301-309 (2010).
148. Oliveira RB, Moraes MO, Oliveira EB, Sarno EN, Nery JA, Sampaio EP: Neutrophils isolated from leprosy patients release TNF-a and exhibit accelerated apoptosis in vitro. J. Leukoc. Biol. 65(3), 364-371 (1999). (Pubitemid 29109710)
149. Moraes MO, Sarno EN, Almeida AS et al.: Cytokine mRNA expression in leprosy: A possible role for interferon-g and interleukin-12 in reactions (RR and ENL). Scand. J. Immunol. 50(5), 541-549 (1999). (Pubitemid 29503461)
150. Moraes MO, Sarno EN, Teles RM et al.: Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients. J. Invest. Dermatol. 115(6), 935-941 (2000). (Pubitemid 32037432)
151. Schuring RP, Hamann L, Faber WR et al.: Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J. Infect. Dis. 199(12), 1816-1819 (2009).
152. Cardoso CC, Martinez AN, Guimaraes PE et al.: Ninjurin 1 asp110ala single nucleotide polymorphism is associated with protection in leprosy nerve damage. J. Neuroimmunol. 190(1-2), 131-138 (2007). (Pubitemid 47628869)
153. Casanova JL, Abel L: Human genetics of infectious diseases: A unified theory. EMBO J. 26(4), 915-922 (2007).
154. Pacheco AG, Moraes MO: Genetic polymorphisms of infectious diseases in case-control studies. Dis. Markers. 27(3), 173-186 (2009).